JL

Jeffrey L. Vacirca

North America, New York, United States, Long Island City

Description

Jeffrey L. Vacirca - CEO & Chairman of the Board @ New York Cancer and Blood Specialists

Investor Profile

Jeffrey L. Vacirca has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Billing
  • Fintech
  • Health Care
  • Medical
  • Payments
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jeffrey L. Vacirca frequently co-invest with?

Thrive Capital
North America, New York, United States, New York
Co-Investments: 1
Kaiser Permanente
North America, California, United States, Oakland
Co-Investments: 1
Crew Capital
North America, New York, United States, New York
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Kinnevik
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Lakestar
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Jeffrey L. Vacirca often collaborate with?

JM
North America, Virginia, United States, Hampton
Shared Deals: 1

What are some of recent deals done by Jeffrey L. Vacirca?

Cedar

New York, New York, United States

Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.

BillingFinTechHealth CareMedicalPayments
Series CJun 22, 2020
Amount Raised: $77,000,000